Donal Geaney, the former chief executive of drug company Elan, has emerged as a backer of a new multi-million euro investment fund, Frontier Equity Partners.
Geaney is a partner in the venture fund, which plans to invest in early-stage biotechnology companies in Ireland, as well as some international companies. David Brabazon, the former vice-president of finance at Elan, is the chief executive of Frontier Equity.
The number of investors in Frontier and the size of...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Get a Business Account for you and your team